Dr Joshi: Vigilance is the key. The drugs must be taken under strict supervision. Common side effects like nausea, vomitting, ...

Stocks to Watch today, December 15, 2025: Indian equities are set for a weaker start on Monday, tracking negative global cues ...

Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Danish pharmaceutical giant Novo Nordisk has introduced its type 2 diabetes treatment, Ozempic, in India. Positioned as a ...

Dozens of units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the FDA, according to a drug safety alert issued by the Agency.

Novo Nordisk introduces Ozempic® (injectable semaglutide) in India, targeting Type 2 diabetes and weight management. Priced ...

Novo Nordisk launched Ozempic in India on Friday—and the weight-loss drug will sell at a massive discount there, compared ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

FDA may expedite approval timeline for Eli Lilly's weight-loss treatment, potentially moving decision date to late March from ...

Novo Nordisk launches Ozempic in India, outlining prices, doses, and its bid to capture rising diabetes and weight-loss ...

Dec 12 () - Danish drugmaker ​Novo Nordisk ‌launched its blockbuster diabetes drug ‌Ozempic in India on Friday. Ozempic, a ...